Top Markets
#1 Black Phoenix Black Phoenix +367.29%
#2 Islamic Coin Islamic Coin +158.24%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.02%
#5 Akedo Akedo +53.30%
#6 Acurast Acurast +37.40%
#7 BasedHype BasedHype +30.34%
#8 Cryptopia Cryptopia +22.42%
#9 Avantis Avantis +21.94%
#10 Playnance Playnance +19.70%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Rank in Stocks #41091
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Share Price
$0.0202
Last synced: 2024-11-19
Market Cap
$44.67K
Change (1 day)
-0.49%
Change (1 year)
0.00%
Country
IL
Trade Notable Labs, Ltd. (NTBL)

Category

Healthcare
Earnings for Notable Labs, Ltd. (NTBL)
Earnings in Jun 2024 TTM: $-8.99M
According to Notable Labs, Ltd. latest financial reports the company's current earnings are $-8.99M. In 2022 the company made an earning of $-14.41M, an increase over its 2021 earnings that were of $-16.05M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Notable Labs, Ltd. from 2015 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $-8.99M -20.23%
2023 $-11.26M -21.82%
2022 $-14.41M -10.25%
2021 $-16.05M -33.74%
2020 $-24.23M 24.90%
2019 $-19.40M -5.19%
2018 $-20.46M 101.80%
2017 $-10.14M -36.65%
2016 $-16.00M 7.48%
2015 $-14.89M 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -58,807.85%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -21,810.07%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -33,552.61%
BE